Ann: Trading Halt, page-9

You are spot on there. The investors conference call is a complete waste of time and money. They can't tell us of this acquisition in the conference call, because it is material. But they could have waited till this acquisition come out first then have the conference calls. They did this probably because they don't want to answer shareholder queries, but they haven't been upfront to the shareholders from day one!

I don't know and don't care whether confidential agreement (between Avita and BARDA) plays any part in this, but this is not the right way of keeping shareholders in the loop.

Once (if) the FDA approval comes, I really want to see how their marketing plan plays out and what sort of revenue we will generate per annum, certainly not the disappointing $500k per quarter.